Blood-brain barrier (BBB) disruption plays a critical role in
brain injury induced by
cerebral ischemia, and preserving BBB integrity during
ischemia could alleviate cerebral injury. We examined the role of miR-130a in ischemic BBB disruption by using models of rat
middle cerebral artery occlusion and cell
oxygen-
glucose deprivation. We found that
ischemia significantly increased microRNA-130a (miR-130a) level and that miR-130a was predominantly from brain microvascular endothelial cells. Antagomir-130a, an antagonist of miR-130a, could attenuate
brain edema, lower BBB permeability, reduce
infarct volume, and improve neurologic function. MiR-130a overexpression induced by miR-130a mimic increased monolayer permeability, and intercellular inhibition of miR-130a by a miR-130a inhibitor suppressed
oxygen-
glucose deprivation-induced increase in monolayer permeability. Moreover, dual
luciferase reporter system showed that Homeobox A5 was the direct target of miR-130a. MiR-130a, by inhibiting Homeobox A5 expression, could down-regulate
occludin, thereby increasing BBB permeability. Our results suggested that miR-130a might be implicated in
ischemia-induced BBB dysfunction and serve as a target for the treatment of
ischemic stroke.-Wang, Y., Wang, M.-D., Xia, Y.-P., Gao, Y., Zhu, Y.-Y., Chen, S.-C.,
Mao, L., He, Q.-W., Yue, Z.-Y., Hu, B. MicroRNA-130a regulates
cerebral ischemia-induced blood-brain barrier permeability by targeting Homeobox A5.